THERABIOGEN, INC. Financing Cash Flow
THERABIOGEN, INC. reported Financing Cash Flow of $44.94 thousand for the 3-month period ending 2012-05-31, per its 10-Q filed 2012-07-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-07-23
- THERABIOGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2012-05-31 was $44.94K, a 71.40% decline year-over-year.
- THERABIOGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2012-02-29 was $405.72K, a 1.93% decline year-over-year.
- THERABIOGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2011-11-30 was $390.58K, a 132.03% increase year-over-year.
- THERABIOGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2011-08-31 was $253.07K.
- THERABIOGEN, INC. net cash provided by (used in) financing activities for fiscal 2012 was $1.21M, a 9.17% decline from fiscal 2011.
- THERABIOGEN, INC. net cash provided by (used in) financing activities for fiscal 2011 was $1.33M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2012-05-31 | $44.94K 10-Q · filed 2012-07-23 | $450.65K derived: sum of 2 quarters · filed 2012-07-23 | $841.24K derived: sum of 3 quarters · filed 2012-07-23 | $1.09M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2012-02-29 | $405.72K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $796.30K derived: sum of 2 quarters · filed 2012-07-18 | $1.05M derived: sum of 3 quarters · filed 2012-07-18 | $1.21M 10-K/A · filed 2012-07-18 | $723.79K 10-K · filed 2012-07-16 |
| 2011-11-30 | $390.58K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-17 | $643.66K derived: sum of 2 quarters · filed 2012-01-17 | $800.79K 10-Q · filed 2012-01-17 | $1.21M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2011-08-31 | $253.07K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-11-17 | $410.21K 10-Q/A · filed 2011-11-17 | $823.91K derived: sum of 3 quarters · filed 2012-07-23 | $992.24K derived: sum of 4 quarters · filed 2012-07-23 | |
| 2011-05-31 | $157.14K 10-Q · filed 2012-07-23 | $570.84K derived: sum of 2 quarters · filed 2012-07-23 | $739.17K derived: sum of 3 quarters · filed 2012-07-23 | ||
| 2011-02-28 | $413.70K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $582.03K derived: sum of 2 quarters · filed 2012-07-18 | $1.33M 10-K/A · filed 2012-07-18 | ||
| 2010-11-30 | $168.33K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-17 | $914.59K 10-Q · filed 2012-01-17 | |||
| 2010-08-31 | $746.26K 10-Q/A · filed 2011-11-17 |